Dr Reddy's falls on concerns Q3 results may miss estimates

RELATED QUOTES

SymbolPriceChange
DRREDDY.NS3,190.70-8.95
SNI62.00-0.10

Reuters Market Eye - Shares in Dr Reddy's Laboratories(NSI:DRREDDY.NS - News) fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day.

Margins are also expected to see significant erosion, several dealers add.

Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at 26.03 rupees compared with mean estimate of 27.89 rupees.

(Reporting by Abhishek Vishnoi)

Market Data

  • Currencies
    Currencies
    NamePriceChange% Chg
    1.3001-0.0021-0.16%
    GBPUSD=X
    1.1597-0.001-0.09%
    GBPEUR=X
    130.7420-0.029-0.02%
    GBPJPY=X
  • Commodities
    Commodities
    NamePriceChange% Chg
    46.11+0.14+0.30%
    BZX16.NYM
    1,328.70-1.70-0.13%
    GCZ16.CMX
    19.14-0.03-0.16%
    SIZ16.CMX
    2.170.00+0.16%
    HGZ16.CMX

TRADING PLATFORM

  • Trade now

    Trade now

    Easy-to-use, award-winning platform from a leader in online trading. Losses can exceed deposits. … More »